These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2957363)

  • 1. Paradoxical aggressive effect of propranolol in a patient with Huntington's disease.
    Stewart JT
    J Clin Psychiatry; 1987 Sep; 48(9):385-6. PubMed ID: 2957363
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive behavior in Huntington's disease: treatment with propranolol.
    Stewart JT; Mounts ML; Clark RL
    J Clin Psychiatry; 1987 Mar; 48(3):106-8. PubMed ID: 2880838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical response to pindolol treatment for aggression in a patient with Huntington's disease.
    von Hafften AH; Jensen CF
    J Clin Psychiatry; 1989 Jun; 50(6):230-1. PubMed ID: 2524472
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reactive syndromes in Huntington's disease].
    Leszek J; Kiejna A; Juskowiak A; Sanecka B; Baran G
    Psychiatr Pol; 1988; 22(5):387-90. PubMed ID: 2977444
    [No Abstract]   [Full Text] [Related]  

  • 5. Propranolol in the treatment of assaultive patients with organic brain disease.
    Greendyke RM; Schuster DB; Wooton JA
    J Clin Psychopharmacol; 1984 Oct; 4(5):282-5. PubMed ID: 6490964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study.
    Greendyke RM; Kanter DR
    J Clin Psychiatry; 1986 Aug; 47(8):423-6. PubMed ID: 3525523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-aggressive effect of beta-blockers].
    Thibaut F; Colonna L
    Encephale; 1993; 19(3):263-7. PubMed ID: 7903928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of aggression in the elderly.
    Yudofsky SC; Silver JM; Hales RE
    J Clin Psychiatry; 1990 Oct; 51 Suppl():22-8; discussion 29-32. PubMed ID: 1976621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychiatric component of Huntington's disease].
    Roccatagliata G
    Riv Neurobiol; 1972; 18(3-4):241-50. PubMed ID: 4282885
    [No Abstract]   [Full Text] [Related]  

  • 10. Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes.
    Horne M; Lindley SE
    J Clin Psychiatry; 1995 Sep; 56(9):430-1. PubMed ID: 7665542
    [No Abstract]   [Full Text] [Related]  

  • 11. Can aggressive behavior in humans be modified by beta blockers?
    Volavka J
    Postgrad Med; 1988 Feb; Spec No():163-8. PubMed ID: 2894657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The measurement of aggressive behavior: reflections on the use of the Overt Aggression Scale and the Modified Overt Aggression Scale.
    Ratey JJ; Gutheil CM
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):S57-60. PubMed ID: 1821223
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential cognitive impairment in Alzheimer's disease and Huntington's disease.
    Brandt J; Folstein SE; Folstein MF
    Ann Neurol; 1988 Jun; 23(6):555-61. PubMed ID: 2970248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid treatment of episodic explosiveness related to brain injury.
    Geracioti TD
    J Clin Psychiatry; 1994 Sep; 55(9):416-7. PubMed ID: 7929025
    [No Abstract]   [Full Text] [Related]  

  • 15. Cycling mood disturbances and progressive neurological symptoms in a patient with Huntington's disease.
    Koskderelioglu A; Binbay IT; Arac N; Veznedaroglu B
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1079-81. PubMed ID: 18343552
    [No Abstract]   [Full Text] [Related]  

  • 16. Dementia and cognitive changes in Huntington's disease.
    Morris M
    Adv Neurol; 1995; 65():187-200. PubMed ID: 7872140
    [No Abstract]   [Full Text] [Related]  

  • 17. Buspirone's efficacy in organic-induced aggression.
    Stanislav SW; Fabre T; Crismon ML; Childs A
    J Clin Psychopharmacol; 1994 Apr; 14(2):126-30. PubMed ID: 8195453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The case of a 86-years old woman first diagnosed with Huntington's disease].
    Jähnel M
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S134-6. PubMed ID: 15570530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
    Greendyke RM; Kanter DR
    J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with propranolol of the behavioral sequelae of brain damage.
    Mansheim P
    J Clin Psychiatry; 1981 Mar; 42(3):132. PubMed ID: 7204354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.